<DOC>
	<DOCNO>NCT01628029</DOCNO>
	<brief_summary>The goal clinical research study learn effect different combination melatonin , supportive counseling , light therapy , methylphenidate/placebo patient cancer sleep problem . The safety treatment combination also study . Methylphenidate design increase activity central nervous system . Melatonin hormone make brain may help let body know time go sleep time wake . A placebo drug . It look like study drug design treat symptom , disease illness . It design compare study drug learn study drug real effect . Light therapy design help people sleep good . Supportive counseling design help control symptom , fatigue , anxiety , depression , pain , and/or sleep disorder . The use therapies treat sleep disturbance combination experimental .</brief_summary>
	<brief_title>Multimodal Therapy Treatment Sleep Disturbance Patients With Advanced Cancer</brief_title>
	<detailed_description>Counseling Physical Activity : If find eligible agree take part , meet counselor . You ask discuss thought feeling different topic related well-being . The counseling session last 30 minute audiotaped quality control . You give watch wear record body movement . This call actigraph . You wear time , except shower bathtub . On Day 15 ( +/- 3 day ) , return watch study staff download information . Study Groups : You randomly assign ( roll dice ) 1 8 study group . You equal chance assign group . You 50 % chance ( like flip coin ) receive placebo capsule light therapy placebo . The skill learn counsel different study group . The study staff talk assign skill . Neither medical study staff know group . If need safety , medical staff able find group . Litebook : All patient use device call Litebook receive either light therapy placebo light 30 minute within 2 hour wake . You 14 day . The placebo light design effect sleep . The Litebook size deck card . To use Litebook , place table within 2 foot sit . You need look directly Litebook usual activity eat read use . The study staff teach use Litebook . Study Diaries : You complete follow diary end day 14-day study period : - The patient diary much light expose use Litebook . - The pill diary medication/placebo . It take 5 minute day make entry study diary . You return diary study staff end study period . Study Drug/Placebo Administration : You take methylphenidate/placebo capsule mouth cup ( 8 ounce ) water , 2 time day . You must take dos 3 PM wait least 2 hour dos . Methylphenidate may take without regard meal store room temperature . You also receive copy FDA-approved Medication Guide specific methylphenidate . You also take Melatonin/placebo capsule mouth cup ( 8 ounce ) water bedtime . Study Visits : For study visits/calls , ask drug may take side effect may . At home study , continue practice skill counsel session use Litebook . You give practice diary record practice home , review session . If do Screening , Baseline ( first visit ) : - Your medical history record . - You physical exam , include measurement vital sign . - You ask complete 6 questionnaire Screening . This take 30 minute total . On Days 3 , 8 , 15 ( +/- 3 day ) return clinic call phone unable return clinic person : - You ask complete questionnaire ask symptom and/or side effect may . This take 10 minute . - You ask complete 4 questionnaire . Each questionnaire take 5 minute complete , total 20 minute . The questionnaire ask : - Your emotional physical well - Your level fatigue - Any anxiety and/or depression may - Any symptom may - On Days 8 15 , counsel session counselor either person phone . This last 30 minute . - On Day 15 , complete questionnaire symptom start study treatment . This take less 5 minute . Length Study Participation : You take study drug/placebo 15 day ( +/- 1 week ) follow visit Day 29 ( +/- 1 week ) . You longer able take study drug/placebo disease get bad , intolerable side effect occur , unable follow study direction , complete enough treatment combination plan . Your participation study complete follow-up visit . Follow-Up Visit : At Day 29 ( +/- 1 week ) last dose study drug/placebo , return clinic follow-up visit . - You ask side effect may . - You physical exam , include measurement vital sign . - Your performance status record . - If do past 15 day , blood ( 1 tablespoon ) drawn routine test . - You ask complete 5 questionnaire . Each questionnaire take 5 minute complete , total 25 minute . The questionnaire ask : - Your emotional physical well - Your level fatigue - Any anxiety and/or depression may - Any symptom may If unable return clinic follow-up visit , research coordinator call ask health complete questionnaires phone . This call last 30 minute . At Day 45 ( +/- 5 day ) 30 day ( +/- 5 day ) receive follow telephone call return follow visit assess side effect treatment . This investigational study . Melatonin investigational drug . Melatonin consider food/nutritional supplement . The use light therapy patient difficulty sleep investigational . It currently use research purpose . The combination methylphenidate , melatonin , light therapy , counsel patient difficulty sleep consider investigational . Up 64 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Patients 18 year old , cancer patient currently cancer therapy positive screening SD ( Screening PSQI score &gt; /= 5 ) . 2 . Patients Zubrod &lt; /= 2 . 3 . Patients pain stable pain ( defined pain control stable dos opioids 1 week ) eligible . 4 . Memorial delirium assessment scale &lt; /= 13 . 5 . Controlled pain depression symptom , present ( defined change Morphine equivalent dose 30 % change dose antidepressant medication past 2 week ) . 6 . All patient receive chemotherapy and/or radiation therapy eligible study complete &gt; 1 week radiation therapy , approve go study primary oncologist . The PI/designated research staff study obtain document approval primary oncologist principal investigator clinical trial case patient another clinical trial reference patient 's study document . 7 . Laboratory test result within range : Serum creatinine &lt; /= 2.0 mg/dL , Total bilirubin &lt; /=1.5 mg/dL , AST ( SGOT ) ALT ( SGPT ) &lt; /=2 x ULN &lt; /= 5 x ULN hepatic metastasis present . ULN= upper limit normal . 8 . Patients stable dos ( define dose 2 week ) dexamethasone , mirtazapine , zolpidem , benzodiazepine , phenothiazine allow participate study . 1 . Have major contraindication methylphenidate ( MP ) ( e.g. , allergy/hypersensitivity study medication constituent ) , light therapy ( e.g. , currently receive UVA/UVB therapy ) , cognitive behavioral therapy ( e.g. , schizophrenia ) , condition make adherence difficult determine attend physician . 2 . Currently take MP take within previous 10 day . 3 . Patients diagnosis polysomnographically confirm obstructive sleep apnea narcolepsy . 4 . Regularly use cognitive behavioral therapy last 6 week sleep disturbance 5 . Unable complete baseline assessment form understand recommendation participation study . 6 . Currently diagnosis major depression , manic depressive disorder , obsessivecompulsive disorder , schizophrenia ) . 7 . Need monoamine oxidase inhibitor , tricyclic antidepressant , clonidine . 8 . Have glaucoma . 9 . Symptomatic tachycardia uncontrolled hypertension ( determine clinically significant PI ) . 10 . Currently receive anticonvulsant ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , clonidine , and/or tricyclic drug ( imipramine , clomipramine , desipramine ) . 11 . Unable speak understand English . 12 . Persons congenital blindness selfreported acquired blindness ( independent cause ) light perception . 13 . Patients history retinal disease . 14 . Patients &gt; 2 hour direct exposure outdoor natural light per day interview Study Coordinator . 15 . Patients diagnosis obesity hypoventilation syndrome . 16 . Positive pregnancy test woman childbearing potential , define intact uterus ovary , history menses within last 12 month . Pregnancy test perform great 14 day prior consent study . In case woman elevate bHCG , candidate eligible participate long level bHCG consistent pregnancy . Women childbearing potential need use contraception , abstinent study period . Their male partner must also use contraception ( condom ) maintain abstinence . Birth control specification : Women able become pregnant must use birth control study 30 day . 17 . Women nurse . 18 . Patients take Melatonin within past two week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Advanced Cancers</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Locally advanced</keyword>
	<keyword>Sleep disturbance</keyword>
	<keyword>Sleep problem</keyword>
	<keyword>Litebook</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Methylphenidate hydrochloride</keyword>
	<keyword>Ritalin</keyword>
	<keyword>Concerta</keyword>
	<keyword>Placebo</keyword>
	<keyword>Supportive counseling</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Study Diaries</keyword>
</DOC>